Moderna Inc. | Mid-cap | Healthcare
$26.80
4.40%
| Moderna Stock Comparison:
Moderna vs VertexModerna vs RegeneronModerna vs AlnylamModerna vs Royalty Pharma plcModerna vs InsmedModerna vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 3.2B
Gross Profit 1.7B 54.24%
Operating Income -3.9B -123.32%
Net Income -3.6B -111.32%
EPS (Diluted) -$9.28

Balance Sheet Metrics

Total Assets 14.1B
Total Liabilities 3.2B
Shareholders Equity 10.9B
Debt to Equity 0.30

Cash Flow Metrics

Operating Cash Flow -2.7B
Free Cash Flow -4.1B

Revenue & Profitability Trend

Moderna Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 3.2B 6.8B 18.9B 17.7B 274.0M
Cost of Goods Sold 1.5B 4.7B 5.4B 2.6B 8.0M
Gross Profit 1.7B 2.1B 13.5B 15.1B 266.0M
Operating Expenses 5.7B 6.3B 4.0B 1.8B 1.0B
Operating Income -3.9B -4.2B 9.4B 13.3B -763.0M
Pre-tax Income -3.6B -3.9B 9.6B 13.3B -744.0M
Income Tax -46.0M 772.0M 1.2B 1.1B 3.0M
Net Income -3.6B -4.7B 8.4B 12.2B -747.0M
EPS (Diluted) -$9.28 -$12.33 $20.12 $28.29 -$1.96

Income Statement Trend

Moderna Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 8.1B 10.3B 13.4B 16.1B 6.3B
Non-Current Assets 6.0B 8.1B 12.4B 8.6B 1.0B
Total Assets 14.1B 18.4B 25.9B 24.7B 7.3B
Liabilities
Current Liabilities 2.2B 3.0B 4.9B 9.1B 4.4B
Non-Current Liabilities 1.0B 1.6B 1.8B 1.4B 387.0M
Total Liabilities 3.2B 4.6B 6.7B 10.5B 4.8B
Equity
Total Shareholders Equity 10.9B 13.9B 19.1B 14.1B 2.6B

Balance Sheet Composition

Moderna Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income -3.6B -4.7B 8.4B 12.2B -747.0M
Operating Cash Flow -2.7B -3.7B 6.9B 12.2B 1.9B
Investing Activities
Capital Expenditures -1.1B -707.0M -400.0M -284.0M -68.0M
Investing Cash Flow 1.9B 4.2B -5.2B -8.5B -1.7B
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow 66.0M -1.1B -3.3B -873.0M 2.0B
Free Cash Flow -4.1B -3.8B 4.6B 13.3B 2.0B

Cash Flow Trend

Moderna Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 24.97
Forward P/E -2.95
Price to Book 0.99
Price to Sales 3.12
PEG Ratio -2.95

Profitability Ratios

Profit Margin -105.67%
Operating Margin -972.22%
Return on Equity -29.34%
Return on Assets -15.84%

Financial Health

Current Ratio 4.22
Debt to Equity 7.40
Beta 1.86

Per Share Data

EPS (TTM) -$8.73
Book Value per Share $26.01
Revenue per Share $8.25

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
mrna 9.9B 24.97 0.99 -29.34% -105.67% 7.40
Vertex 117.0B 32.82 7.09 -5.64% -8.91% 10.00
Regeneron 55.3B 13.02 1.84 15.96% 31.94% 9.20
Alnylam 40.8B - 353.42 -414.62% -11.49% 2,358.26
Royalty Pharma plc 20.3B 14.75 2.30 18.00% 48.26% 77.82
Insmed 20.0B - 193.43 -320.20% -265.93% 1,316.96

Financial data is updated regularly. All figures are in the company's reporting currency.